Your browser doesn't support javascript.
Covid-19 and Thrombotic Thrombocytopenic Purpura: A Case Report.
Darnahal, Maryam; Azhdari Tehrani, Hamed; Vaezi, Mohammad; Haghighi, Shirin.
  • Darnahal M; Department of Hematology and Medical Oncology, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Azhdari Tehrani H; Department of Hematology and Medical Oncology, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Vaezi M; Hematology, Oncology and Stem Cell Transplantation Research Center, Tehran University of Medical Sciences, Tehran, Iran.
  • Haghighi S; Department of Hematology and Medical Oncology, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Int J Hematol Oncol Stem Cell Res ; 15(1): 72-74, 2021 Jan 01.
Article in English | MEDLINE | ID: covidwho-1068116
ABSTRACT
Endothelial injury by toxins, drugs, immune complexes leads to activation of coagulation cascade and thrombosis, which result in platelet consumption and red blood cell injury. These thrombotic microangiopathies can potentially injure numerous organs and result in organ dysfunction. In this case, we present the fourth reported patient with thrombotic thrombocytopenic purpura associated with COVID-19.
Keywords
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Type of study: Case report Language: English Journal: Int J Hematol Oncol Stem Cell Res Year: 2021 Document Type: Article Affiliation country: Ijhoscr.v15i1.5251

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Type of study: Case report Language: English Journal: Int J Hematol Oncol Stem Cell Res Year: 2021 Document Type: Article Affiliation country: Ijhoscr.v15i1.5251